MacOrtho is pleased to announce that the FAITH-2 pilot study has initiated patient enrollment. The pilot study will enroll 50 patients across clinical sites in Canada and the US in order to determine the feasibility of a larger definitive trial. The FAITH-2 study is a randomized controlled trial which uses a 2x2 factorial design to assess the impact of surgical implant (sliding hip screw versus cancellous screws) and nutritional supplement (4,000 IU of vitamin D versus placebo) on patient important outcomes for young adults (ages of 18 and 60) with femoral neck fractures. The composite of patient important outcomes includes: re-operation, femoral head osteonecrosis, severe femoral neck malunion, and nonunion. The secondary objectives are to assess the impact of surgical implant and nutritional supplementation on health-related quality of life and functional outcomes, fracture healing complications, and radiographic fracture healing. Led by Drs. Gerard Slobogean and Mohit Bhandari, this trial will have global impact on the management of these complex injuries and potentially lead to exploring the use of nutritional supplementation in femoral neck fracture treatment for younger patients.